Fluid Synchrony, LLC was incorporated in California in January 2010 with the aim of commercializing the FluidSyncTM micropump drug delivery technology originally developed at University of Southern California (USC). Based on award-winning research conducted at USC’s Biomedical Microsystem Laboratory under direction of Prof. Ellis Meng, the FluidSync micropump technology has evolved to serve the drug delivery needs of scientific and clinical researchers alike. Based in Los Angeles, California, FluidSynchrony is within easy access of the growing biotech and medtech hubs of Orange Country and within reach of three of the world’s leading research universities (USC, UCLA, Caltech).